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Abstract
A role for microbes has been suspected in prostate cancer but difficult to confirm in human patients. We show here
that a gastrointestinal (GI) tract bacterial infection is sufficient to enhance prostate intraepithelial neoplasia (PIN) and
microinvasive carcinoma in a mouse model. We found that animals with a genetic predilection for dysregulation of
wnt signaling, ApcMin/+ mutant mice, were significantly susceptible to prostate cancer in an inflammation-dependent
manner following infection with Helicobacter hepaticus. Further, early neoplasia observed in infected ApcMin/+ mice
was transmissible to uninfected mice by intraperitoneal injection of mesenteric lymph node (MLN) cells alone from H.
hepaticus-infected mutant mice. Transmissibility of neoplasia was preventable by prior neutralization of inflammation
using  anti-TNF-α  antibody  in  infected  MLN  donor  mice.  Taken  together,  these  data  confirm  that  systemic
inflammation triggered by GI tract bacteria plays a pivotal role in tumorigenesis of the prostate gland.
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Introduction
Only  a  small  proportion  of  dysplastic  and  early  neoplastic
lesions  arising  in  epithelia  throughout  the  body  actually
advance  into  cancer  [1–3].  Cancer  happens  when  cells  with
malignant potential achieve all stimuli needed for their genetic
and  epigenetic  evolution  into  malignancy  [4].  It  is  now  well
documented that for many types of cancer a major contributor
is cells and factors of the immune system [4–6]. In the prostate
gland,  several  lines  of  evidence  suggest  that  chronic
inflammation drives the prostate cancer process [5,7,8], but its
source remains elusive. Infectious agents, chemical or physical
epithelial cell injury, hormonal imbalances and dietary factors
have been proposed as the most probable causes of chronic
inflammation in the prostate [8–10].
Determining  whether  prostate  malignancy  may  be
preventable by targeting underlying inflammation has particular
importance  since  it  is  a  leading  cause  of  cancer-related
disability  and  death  among  men.  In  the  gastrointestinal  (GI)
tract,  infections  with  pathogenic  microbes,  such  as  with
Helicobacter pylori, lead to chronic inflammation (gastritis) and
cancer  (gastric  adenocarcinoma)  in  humans  and  in  mouse
models [4]. Likewise, in immunocompromised mouse models
the related lower bowel bacterium Helicobacter hepaticus (H.
hepaticus)  triggers  inflammatory  bowel  disease  (IBD)  and
colorectal  carcinoma  (CRC)  [11–13].  In  the  prostate  gland,
however,  few  animal  models  exist  to  test  possible  direct  or
even  indirect  roles  of  pathogenic  microbes  in  prostate
malignancy [8,10,14].
In humans, the adenomatosis polyposis coli (Apc) gene is a
critical  tumor  suppressor  gene  that  prevents  malignancy  of
prostate and other tissues [15]. Here, we use mutant mice that
lack  one  copy  of  the  Apc  gene  (ApcMin/+  mice)  and  exhibit
dysregulation of β-catenin and the wnt signaling pathway and
are  otherwise  extensively  used  as  a  model  of  intestinal
adenomas [16]. ApcMin/+ mice spontaneously develop prostate
intraepithelial  neoplasia  (PIN)  and  microinvasive  carcinoma
(microinvasive  CA)  with  increasing  age,  mimicking  the  initial
stages of prostate cancer seen in humans in their fifth or sixth
decade of life [15,17]. We show that orogastric dosing with H.
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bowel  colonizer  [17],  significantly  increases  prostate  cancer.
Importantly, development of prostate cancer was transmissible
to uninfected animals solely by transfer of mesenteric lymph
node cells from H. hepaticus-infected ApcMin/+ donor mice.
Results
Orogastric infection with Helicobacter hepaticus
increases risk of prostate carcinoma in male ApcMin/+
mice
To  determine  the  impact  of  intestinal  infection,  we  used
ApcMin/+ mice that were cancer-free (young mice at age of 12
weeks  had  no  prostate  carcinoma  or  intestinal  polyps)  [17].
Mice were orally dosed with H. hepaticus or underwent sham
dosing with media at six weeks of age. By 12 weeks of age,
ApcMin/+ mice infected with H. hepaticus displayed features of
prostate carcinoma consistent with those observed in human
males (Figure 1A, 1B; Table S1). H. hepaticus-infected ApcMin/+
mice  exhibited  increased  PIN  (p<0.01)  and  microadenoCA
(p<0.01) when compared with sham-dosed matched uninfected
control ApcMin/+ mice (Figure 1C and S1). Neither H. hepaticus-
infected  nor  uninfected  12-week-old  wt  mice  exhibited
significant  prostate  pathology.  Together  these  results
demonstrate  that  infection  of  the  GI  tract  with  H.  hepaticus
rapidly  enhances  prostate  carcinogenesis  in  genetically
susceptible mice.
Elevations of inflammatory cytokines occur without
overt inflammatory disease in H. hepaticus–infected
ApcMin/+ mice
We  next  tested  whether  H.  hepaticus  infection  leads  to
increased  inflammatory  responses  as  previously  shown  [13].
We  found  that  H.  hepaticus-infected  ApcMin/+  mice  exhibited
increased systemic pro-inflammatory cytokines including tumor
necrosis  factor  (TNF)-α  (p=0.013),  IL-1α  (p=0.024),  IL-3
(p=0.0009) and eotaxin (p=0.003) (Figure 2A left). Interestingly,
prostates from H hepaticus-infected ApcMin/+ mice lacked overt
inflammatory  disease  but  exhibited  occasional  mast  cells,
neutrophils,  and  also  myeloid  precursor  cells  bearing  ring-
shaped nuclei [18] (Figure 1D).
Neutralization of inflammation inhibits H. hepaticus–
induced prostate carcinoma in male ApcMin/+ mice
Pro-inflammatory cytokine TNF-α was found to be elevated
(p= 0.013) in sera after H. hepaticus infection for six weeks in
three-month-old male ApcMin/+ mice (Figure 2A). TNF-α is at the
apex of a cascade of carcinogenic pro-inflammatory events [5].
To test whether inflammation is required for GI tract bacteria-
triggered  prostate  pathology,  we  performed  systemic
neutralization of TNF-α using intraperitoneal injection of anti-
TNF-α antibody for 3 weeks duration starting at 3 weeks post-
infection  (PI).  We  found  that  anti-TNF-α  treatment  led  to
significantly less (p<0.01) prostate pathology in H. hepaticus-
infected ApcMin/+ mice (Figure 1A, 1C and S1; Table S1). Taken
together  with  earlier  data,  this  indicated  that  H.  hepaticus-
triggered  host  inflammatory  responses  enhanced  neoplastic
effects in prostate tissue.
Inflammatory cytokines were elevated in H. hepaticus-
infected ApcMin/+ mice but not in H. hepaticus-infected
wt littermate mice
A feature of this mouse model is that H. hepaticus-infected
ApcMin/+ mice displayed significantly increased high grade PIN
(HGPIN)  and  prostate  carcinoma;  however,  matched  H.
hepaticus-infected wt littermate mice fail to develop significant
PIN or carcinoma lesions (Figure 1B, 1C and S1, Table S1).
Upon  analysis  of  serum  cytokine  levels,  we  discovered
significant  differences  in  protein  levels  of  IL-1α  (p=0.02)  and
IL-17 (p=0.0005) between ApcMin/+ and the wt littermate mice
(Figure  2A  right).  Likewise,  in  situ  labeling  of  IL-17  showed
increased  IL-17+  expression  levels  in  MLN  in  H.  hepaticus-
infected ApcMin/+ mice but not in the H. hepaticus-infected wt
controls  (Figure  2B  and  2C).  Treatment  of  H.  hepaticus-
infected  ApcMin/+  mice  with  anti-TNF-a  antibody  significantly
decreased  mRNA  gene  expression  (p<0.01)  and  protein
(p<0.001) levels of IL-17A in MLN (Figure 2B and 2C). Taken
together,  these  accumulated  data  raised  the  possibility  that
systemic  differences  originating  from  bacteria-triggered
inflammation of GI tract origin may contribute to carcinogenic
processes in distant tissues such as prostate.
Prostate cancer risk is transmissible to uninfected
recipients using mesenteric lymph node (MLN) cells
from H. hepaticus-infected ApcMin/+ mice
Knowing  that  GI  tract  origin  inflammatory  response  is
necessary for prostate cancer in our model, we hypothesized
that  cells  within  gut-associated  lymph  nodes  (MLN)  may  be
pivotal  in  prostate  cancer  in  this  model.  In  order  to  test  this
hypothesis, we utilized cell transfer of MLN collected from H.
hepaticus-infected  or  sham-dosed  donor  ApcMin/+  or  wt
littermate  mice  (Figure  3).  For  this  experiment,  all  recipient
animals  were  Helicobacter  sp-free  male  ApcMin/+  or  wt
littermates. Male mice of age 6-8 weeks underwent ip injection
of 5X106 single cell suspension in HBSS per mouse of cells
gathered  from  mesenteric  lymph  nodes  of  H.  hepaticus-
infected or sham-dosed ApcMin/+ or wt mice.
Consequently, we found significantly increased low (p<0.05)
and high grade (p<0.01) PIN in uninfected ApcMin/+ mice that
had  merely  received  MLN  cells  from  H.  hepaticus-infected
ApcMin/+  mice  (Figure  1A,  B,  C  and  S1)  at  6  weeks  after  ip
injection,  when  compared  with  MLN  donor  cells  from  sham-
dosed  ApcMin/+  mice.  These  uninfected  ApcMin/+  that  received
cells from H. hepaticus-infected ApcMin/+ displayed features of
preneoplasia and carcinoma consistent with those observed in
H. hepaticus-infected ApcMin/+ mice (Figure 1A), and resembling
those seen in human males. In addition, uninfected wt recipient
mice that received lymph node cells from H. hepaticus-infected
ApcMin/+  donor  mice  also  had  increased  LGPIN  (p<0.001),
HGPIN (p<0.001) and adenocarcinoma (p<0.001) (Figure 1C
and  S1;  Table  S1)  compared  to  uninfected  wt  mice  that
received lymph node cells from H. hepaticus-free ApcMin/+ donor
mice showing that genetic predisposition of prostate epithelia
was  not  specifically  required  for  carcinogenic  effect  of  H.
Intestinal bacteria and prostate cancer
PLOS ONE | www.plosone.org 2 August 2013 | Volume 8 | Issue 8 | e73933Figure 1.  Clinically silent immune system alterations affect dorsolateral prostate (DLP) carcinogenesis in B6 ApcMin/+
mice after GI infection with H. hepaticus.  A) By the age of 12 weeks, ApcMin/+ mice spontaneously develop focal low and high
grade prostate intraepithelial neoplasia (LGPIN, white arrow-head; HGPIN, black arrow-head) but only rare microinvasive carcinoma
(a).  Aged-matched  ApcMin/+  mice  with  H.  hepaticus,  develop  significantly  more  PIN  and  microinvasiveCA  lesions  (asterisk)
characterized by highly atypical prostate gland epithelial cells which break through the basal lamina and infiltrate the adjacent
stroma (b). When mesenteric lymph node cells from H. hepaticus-infected ApcMin/+ mice are transferred into the peritoneal cavity of
H. hepaticus-free ApcMin/+ mice the recipient mice develop preneoplastic and early neoplastic lesions (microinvasiveCA-asterisk)
comparable to those found in donor mice (c). Depleting TNF- α from H. hepaticus-infected ApcMin/+ mice brings prostate neoplastic
lesions (LGPIN, white arrow-head) occurrence to the level of H. hepaticus-free mice (d). Hematoxylin and Eosin. Bars=50 μm. B)
Aberrant β-catenin and laminin immunostaining pattern in microinvasiveCA lesions in prostate cancer. DLP from WT H. hepaticus-
positive mice (a and c), H. hepaticus-infected ApcMin/+ mouse (b) and H. hepaticus-free ApcMin/+ mouse transferred with mesenteric
lymph node cells from H. hepaticus-infected ApcMin/+ donor (d). Normal DLP glands had a normal β-catenin lateral epithelial cell
membrane  staining  pattern  (a)  and  an  intact  basal  lamina  (c).  In  contrast,  microinvasiveCA  lesions  were  characterized  by
cytoplasmic  and  nuclear  (arrow-heads)  stabilization  of  β-catenin  (b)  and  absence  of  laminin  (asterisk)  suggestive  of  basal
membrane degradation in malignant epithelial cell foci of incipient invasion. Hematoxylin counterstain, DAB chromogen. Bars=25
μm. C) Bar graph showing frequency of PIN and microinvasiveCA in treatment groups. The most significantly elevated prostate
cancer occurrence is denoted by asterisk. Standard error bars correspond to microinvasiveCA statistical comparisons. D) DLP of H.
hepaticus-free  ApcMin/+  mouse  transferred  with  MLN  cells  from  a  H.  hepaticus-infected  ApcMin/+  donor,  HGPIN.  Most  myeloid
precursor cells with ring-shaped nuclei residing in the stroma have the typical granulocytic lineage phenotype (black arrow-head)
while fewer appear to be myelo/monocytic in type (white arrow-head). Bar=16 μm.
doi: 10.1371/journal.pone.0073933.g001
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PLOS ONE | www.plosone.org 3 August 2013 | Volume 8 | Issue 8 | e73933Figure 2.  Intestinal H. hepaticus infection triggers systemic elevations in pro-inflammatory cytokines.  A) Serum levels of
pro-inflammatory  cytokines  were  increased  in  ApcMin/+  mice  after  H.  hepaticus  infection.  Eotaxin,  IL-3,  TNF-α  and  IL-1α  were
significantly elevated in comparison with age-matched uninfected ApcMin/+ controls. When compared with H. hepaticus infected wt
mice, infected ApcMin/+ mice had significantly higher IL-17, IL-1α, IL-3, eotaxin and IL-9 concentration in their blood serum. Bio-Plex
Cytokine  Assay  used  sera  of  n=5  mice  per  group.  ***p<0.001;  *p<0.05.  B)  Paracortical  areas  in  mesenteric  lymph  nodes.  H.
hepaticus  infected  ApcMin/+  mice  at  high  risk  of  prostate  cancer  had  large  amounts  of  cytoplasmic  and  extracellular  IL-17  that
significantly decreased after depletion of TNF-α. IL-17-specific immunohistochemistry; Hematoxylin counterstain, DAB chromogen.
Bars=25 μm. C) Morphometric assessment of IL-17 in immunohistochemically stained sections of mesenteric lymph nodes. Both
ApcMin/+  genetic  status  and  intestinal  infection  by  H.  hepaticus  significantly  correlate  with  a  TNF-α-mediated  increase  of  IL-17
expression in the mesenteric lymph nodes. ***p<0.001; **p<0.01; *p<0.05.
doi: 10.1371/journal.pone.0073933.g002
Intestinal bacteria and prostate cancer
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hepaticus-activated  cells  were  sufficient  for  neoplastic
processes in extra-intestinal glands such as prostate.
Neutralization of inflammation prevents MLN cell
transmissibility of prostate cancer risk to uninfected
mice
Finally,  we  tested  whether  neutralizing  inflammation  was
sufficient  to  inhibit  MLN-cell  mediated  transmissibility  of
prostate cancer in this mouse model. We utilized cell transfer of
MLN collected from H. hepaticus-infected ApcMin/+ mice that had
been treated with anti-TNF-a antibody for 3 weeks (Figure 3).
For this experiment, all recipient animals were Helicobacter sp-
free male ApcMin/+ or wt littermate animals. Male mice of age 6-8
weeks underwent ip injection of 5X106 single cell suspension in
HBSS  per  mouse  of  cells  gathered  from  mesenteric  lymph
nodes of H. hepaticus-infected ApcMin/+ mice. As predicted, we
found  no  significant  differences  between  uninfected  ApcMin/+
mice vs uninfected ApcMin/+ mice that had received MLN from
anti-TNF-α-treated  mice  (p>0.05).  Likewise,  there  was
significantly  less  LGPIN  (p<0.01)  and  HGPIN  (p<0.05)  in
uninfected ApcMin/+ recipients of MLN from anti-TNF-treated H.
hepaticus-infected mice when compared with ApcMin/+ recipient
Figure 3.  Transfer of mesenteric lymph node (MLN) cells from H hepaticus-infected mice is sufficient to recapitulate
prostate cancer in uninfected mice.  Schematic illustration of MLN cells transfer experiments designed to test the hypothesis that
local GI tract immune network events cause systematic immune imbalances that determine the fate of preneoplastic lesions in
topographically distant epithelia such as those of the prostate gland. Trials used 6 mice per group. Experiments were done in
duplicate.
doi: 10.1371/journal.pone.0073933.g003
Intestinal bacteria and prostate cancer
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1C  and  S1;  Table  S1).  These  data  indicate  that  the  pro-
inflammatory role of the MLN cells is the underlying cause of
the observed prostate cancer risk transmissibility.
Discussion
In the present study, we test young male ApcMin/+ mice on a
C57BL/6J  background  as  an  experimental  model  to  probe
associations  of  inflammation  with  carcinogenesis  in  the
prostate.  As  with  humans  where  prostate  cancer  risk  has  a
strong genetic component, ApcMin/+ mutant mice are genetically
predisposed to epithelial neoplasia [13,16,17]. We and others
have shown in the past that ApcMin/+ mice also progressively
develop prostate cancer on the basis of increased PIN lesions
matching  that  seen  in  human  males  [15,17].  In  our  studies,
ApcMin/+  mice  develop  early  neoplastic  lesions  in  the
dorsolateral prostate as early as at 3 months of age preceding
evident intestinal polyps. At age = 6 months, 40% of ApcMin/+
mice  develop  microinvasive  adenocarcinoma  while  10-20%
also  have  more  advanced  prostate  cancer  lesions  [15].  This
aspect gives the ApcMin/+ mouse utility as a model to examine
progression  of  pre-neoplastic  and  early  neoplastic  lesions  in
the human prostate [1–3].
An  important  finding  of  this  study  is  that  infection  with  H.
hepaticus,  a  bacterium  that  colonizes  primarily  the  large
intestine  of  C57BL/6  ApcMin/+mice  without  overt  typhlocolitis
[13,19–21],  significantly  increased  the  incidence  of  PIN  and
microinvasive  adenocarcinoma  lesions  in  the  prostate.  As
expected, 3-months-old ApcMin/+ mice infected with H. hepaticus
had  neither  overt  IBD  nor  large  adenomatous  polyps  yet
formed in their bowels (data not shown). However, even at this
young  age,  these  mice  did  exhibit  increased  systemic  pro-
inflammatory  cytokines,  such  as  TNF-α,  IL-1α,  IL-3,  eotaxin
and  IL-9,  compared  to  their  uninfected  control  counterparts,
indicative  of  immune  system  activation.  These  data  taken
together with previous evidence that H. hepaticus infection is
able to modulate tumorigenesis at extra-intestinal sites [21,22],
suggest  that  clinically  silent  GI  tract  immune  network  events
triggered  by  gut  microbiota  may  cause  systematic  immune
imbalances. In turn, these imbalances may impact the fate of
preneoplastic lesions in topographically distant epithelia such
as those of the prostate gland.
The  interrelated  roles  of  the  elevated  proinflammatory
cytokine milieu and the inflammatory cellular component found
in the prostate cancer prone H. hepaticus-infected ApcMin/+ mice
are  interesting.  Within  the  prostate  gland,  PIN  and
microinvasive  adenocarcinoma  featured  mast  cells,
neutrophils,  and  myeloid  precursor  cells  bearing  ring-shaped
nuclei.  TNF-α  was  previously  proven  essential  in  mast  cell
recruitment and tumorigenesis in ApcMin/+ mice [13,17,23]. The
release of factors including TNF-α and various proteases from
mast  cells  residing  in  the  prostate  stroma  may  have  an
important role in tumorigenesis [10].
TNF-α and IL-1α have been together implicated in a NF-κB-
mediated signal cascade that inhibited apoptosis and increased
the  proliferation  of  epithelial  cells  in  human  prostate
preneoplasia and cancer [24]. In addition, IL-1α promotes the
abnormal  proliferation  of  human  prostate  epithelial  cells
through  insulin  growth  factor-  and  fibroblast  growth  factor-7-
related growth signals [25,26]. Eotaxin and IL-3 regulate bone
marrow  maturation,  release  and  tissue  trafficking  of  myeloid
precursor cells [27] such as those seen in prostate glands of H.
hepaticus-infected ApcMin/+ mice. Potential roles of eotaxin, IL-3
and  associated  myeloid  precursor  cells  in  epithelial
carcinogenesis warrant further investigation. The powerful pro-
inflammatory role of IL-9 is increasingly appreciated. Th9 cells
constitute the latest addition expanding the T-helper subtype
array.  IL-9  stimulates  the  growth  of  hematopoietic  cells,
especially mast cells and the secretion of several chemokines
that  recruit  additional  cells  to  inflamed  tissues  [28].  The
important  role  of  IL-9  in  autoimmunity  and  allergy  [28]  may
provide  important  clues,  especially  in  the  light  of  recent
hypotheses  that  connect  prostate  inflammation  with  cancer.
Prostate epithelial cell injury may then cause loss of tolerance
to normal prostatic antigens and consequently lead to a self-
perpetuating autoimmune reaction [10]. In the present study,
our  finding  that  neutralization  of  TNF-α  was  sufficient  to
counteract  prostate  cancer  risk  enhancement  in  a  mouse
model suggests that this cytokine has a central role in creating
a pro-tumorigenic systematic inflammatory macro-environment
that allows the progression of cancer in the prostate gland.
Another  pro-inflammatory  cytokine  we  found  significantly
elevated by comparing H. hepaticus-infected ApcMin/+ mice with
H.  hepaticus-infected  wt  littermate  mice  was  Il-17A.  The
significant  differences  in  Il-17  were  of  particular  interest
because we have previously shown IL-17+ cells in mesenteric
lymph  node  (MLN)  of  mice  after  infection  with  H.  hepaticus
[20]. Likewise, IL-17 has been implicated in infection-triggered
bowel  cancer  development  in  ApcMin/+  mice  [29,30].  The
correlation of the ApcMin/+ mouse genotype with systematic and
MLN elevations in Il-17 expression may have a genetic basis,
since  Il-17-associated  deficits  in  the  immune  cell  function  of
this mouse model have been reported [30]. Importantly, recent
evidence from both preclinical mouse [31] and clinical human
studies  support  a  significant  role  for  Il-17  in  prostate
carcinogenesis [32,33].
To provide experimental proof for this hypothesis and retain
the  complex  immunological  interplay  of  the  various  cell
populations we chose to transfer total MLN cell populations into
mice.  Immunological  activities  within  systemic  lymph  node
tissue [20] may be the link connecting GI microbial flora with
universally  pro-tumorigenic  systematic  alterations  of  the
immune system. Surprisingly, we found that increased prostate
cancer risk is transmissible to uninfected ApcMin/+ recipients of
MLN  cells  only  taken  from  H.  hepaticus-infected  ApcMin/+
donors. There was no evidence of H. hepaticus organisms in
prostate tissue of transplant recipient mice using PCR or by in
situ  examination  using  silver  stain  (data  not  shown),  but
translocation of H. hepaticus organisms or their antigens from
intestines to lymph nodes remain a possible contributing factor.
Our  finding  that  MLN  cells  taken  from  anti-TNFα-treated  H.
hepaticus-infected ApcMin/+ lost the prostate cancer promoting
effects  provides  evidence  that  inflammation  enhanced  this
carcinogenic process.
Intestinal bacteria and prostate cancer
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malignancy  has  been  suspected  [9]  but  remained  unproven
until  now.  Here  we  have  demonstrated  that  ingestion  of  H.
hepaticus alone enhanced prostate carcinogenesis in ApcMin/+
mice.  Our  finding  that  inflammation  enhanced  this  cancer
forming  process  adds  mechanistic  support  to  the  well-
documented benefits of non-steroidal anti-inflammatory drugs
(NSAIDs) in human patients. Remarkably, uninfected mice that
received only lymph node cells became highly susceptible to
prostate  cancer.  This  observation  that  prostate  cancer  is
inducible by distilled cells from another organ may help explain
why etiopathogenesis of prostate cancer in humans has been
difficult  to  elucidate.  It  remains  to  be  definitely  determined
whether other GI tract microbes in humans, such as H pylori,
may  have  a  similar  effects  in  prostate  and  other  non-
gastrointestinal cancers of humans.
Materials and Methods
Experimental animals
All  animals  were  housed  and  handled  in  Association  for
Assessment  and  Accreditation  of  Laboratory  Animal  Care
(AAALAC)-accredited  facilities  with  diets,  experimental
methods,  and  housing  as  specifically  approved  by  the
Institutional Animal Care and Use Committee. The MIT CAC
(IACUC)  specifically  approved  the  studies  as  well  as  the
housing  and  handling  of  these  animals.  ApcMin/+  mice  on  a
C57BL/6J  background  were  originally  obtained  from  the
Jackson labs and bred in-house to provide ApcMin/+ mice and
wildtype (wt) littermates for experimental recipients and donors.
Helicobacter-free  status  of  the  mice  was  confirmed  by  PCR
using  Helicobacter  genus-specific  primers  as  previously
described [20].
Experimental Helicobacter hepaticus infection
A total of 44 experimental mice were dosed at 6 weeks of
age  with  H.  hepaticus  (strain  3B1,  ATCC  #51449)  and  then
housed separately in a bio-containment area within the same
animal  facility.  H.  hepaticus  was  grown  under  microaerobic
conditions,  prepared,  and  confirmed  pure  as  described
elsewhere [11,20]. Experimental mice received 0.2ml of fresh
inoculum by gastric gavage every other day for a total of three
doses.  Cecum,  mesenteric  lymph  node  (MLN),  and  prostate
were  collected  6  weeks  post-infection  at  necropsy  and
analyzed by PCR to confirm (bowel) or exclude (MLN, prostate)
colonization.
Experimental design
A total of 96 ApcMin/+ mice and 60 wt mice were included in
various  treatment  regimens  or  as  experimental  controls.
Experiments were conducted using two separate trials with 5-6
mice each, as specified in Table S1. Sixty ApcMin/+ mice and 40
wt mice age of 6 weeks were injected intraperitoneally with 5 x
106 MLN cells suspended in HBSS. The cell donor mice were
male H. hepaticus-infected six weeks earlier, or Helicobacter-
free C57BL/6 wt or ApcMin/+ mice.
TNF-α neutralization
A total of 24 H. hepaticus infected ApcMin/+ or wt mice at age
of 9 weeks (starting at 3 weeks after H. hepaticus infection)
received  anti-TNF-α  antibody  (clone  XT-3;  BioExpress,
Lebanon, NH) at 200µg per mouse three times weekly for three
weeks as described previously [13].
Detection of systemic cytokine protein expression
Serum cytokine levels of 5-6 animals in each experimental
group  were  analyzed  using  the  Bioplex  Pro  Mouse  Cytokine
assay  system  (BioRad,  Hercules,  CA)  according  to  the
manufacturers  protocol.  Briefly,  serum  samples  were  diluted
using  the  sample  diluent  kit,  incubated  with  antibody  coated
beads  followed  by  a  secondary  antibody  incubation  and
analyzed  in  duplicates  on  a  Bio-Plex  200  system  (BioRad,
Hercules, CA).
Histologic evaluation and Immunohistochemistry
The  formalin-fixed  tissues  were  processed  and  paraffin
embedded 5µm tissue-sections were stained by H&E, Warthin-
Starry silver stain or IHC and evaluated for prostate lesions by
a  veterinary  pathologist  blinded  to  sample  identity.  The
preneoplastic  and  early  neoplastic  prostate  lesions,  detected
based  on  recent  consensus  report  criteria  [34],  were
quantitatively assessed as described previously by Poutahidis
et al (2009) [17].
Rabbit  primary  antibodies  used  for  immunohistochemistry
included  anti-β-catenin  (Thermo,  Fisher  Scientific/Lab  Vision,
Fremont,  CA),  anti-laminin  (Thermo,  Fisher  Scientific/Lab
Vision, Fremont, CA) and anti-IL17 (Santa Cruz Biotechnology,
Santa  Cruz,  CA).  Antigens  were  retrieved  with  Protease  1
(Roche Diagnostics/Ventana Medical Systems, Tucson, AZ) for
laminin  detection.  Heat-induced  antigen  retrieval  was
performed with citrate buffer pH6 for β-catenin or with EDTA
buffer  pH8  for  IL17  detection.  Primary  antibody  binding  was
detected  with  goat  anti-rabbit  Zytochem  Plus  HRP  Polymer
(Zytomed Systems, Berlin, Germany). Signal was detected with
diaminobenzidine (Invitrogen, Camarillo, CA) and tissues were
counterstained with hematoxylin.
For the quantification of IL-17 expression in MLN, thirty 40x
high power field images of IHC-stained sections were captured
per  treatment  group.  Ten  images  from  each  group  were
randomly  selected  for  counts.  Automatic  calculation  of  the
numbers of pixels corresponding to IL-17 in images appeared
in a histogram after processing each image with the threshold
color  plug-in  of  the  ImageJ  image  processing  and  analysis
program  (NIH,  Bethesda,  MD).  Morphometric  counts  were
recorded as the number of IHC labeled pixels per image.
Statistical analyses
The  prevalence  of  LGPIN,  HGPIN  and  micro-adenoCa
between groups was compared by the Kruskal-Wallis one-way
ANOVA and Dunn’s post-test. Direct comparisons were made
by  the  Mann–Whitney  U  test.  Serum  cytokine  data  analysis
was  performed  using  the  2-tailed  student’s  t-test.  IL-17
immunohistochemically-positive  image  pixel  count  data  were
evaluated  for  normality  with  Shapiro-Wilk  test  and  analyzed
Intestinal bacteria and prostate cancer
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multiple  comparison  post  test.  Statistical  analyses  were
performed  with  Graphpad  Prism  version  5.0  for  Windows,
GraphPad  software,  San  Diego,  CA,  USA;  a  p-value  <  0.05
was considered statistically significant.
Supporting Information
Figure  S1.    Statistical  analyses  of  prostate  pathology  in
treatment groups. Treatment groups match those portrayed in
Figure 1. ***p<0.001; **p<0.01; *p<0.05.
(TIF)
Table S1.  Frequency of prostate pathology types within
treatment groups.
(DOC)
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